DDIT3 Recombinant Rabbit Monoclonal Antibody [PSH07-65]
cat.: HA722854
Product Type: Recombinant Rabbit monoclonal IgG, primary antibodies
Species reactivity: Human, Mouse, Rat
Applications: WB, IF-Cell, FC
Clonality: Monoclonal
Clone number: PSH07-65
Form: Liquid
Storage condition: Store at +4℃ after thawing. Aliquot store at -20℃. Avoid repeated freeze / thaw cycles.
Storage buffer: PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration: 1ug/ul
Purification: Protein A affinity purified.
Molecular weight: Predicted band size: 19 kDa
Isotype: IgG
Immunogen: Recombinant protein within human DDIT3 aa 1-169.
Positive control: HeLa treated with 2μg/mL tunicamycin for 8 hours cell lysate, C2C12 treated with 2μg/mL thapsigargin for 8 hours cell lysate, C6 cell lysate, C6 treated with 2μg/mL tunicamycin for 8 hours cell lysate, HeLa cells treated with 2μg/mL tunicamycin for 8 hours, C2C12 cells treated with 2μg/mL thapsigargin for 8 hours, C6 cells treated with 2μg/mL tunicamycin for 8 hours.
Subcellular location: Cytoplasm, Nucleus.
Recommended Dilutions:
  WB
  IF-Cell
  FC

1:5,000
1:100
1:1,000
Uniprot #: SwissProt: P35638 Human | P35639 Mouse | Q62857 Rat
Alternative names: C/EBP homologous protein C/EBP Homology Protein C/EBP zeta C/EBP-homologous protein 10 C/EBP-homologous protein CCAAT/enhancer binding protein homologous protein CEBPZ CHOP 10 CHOP CHOP-10 CHOP10 DDIT 3 DDIT-3 Ddit3 DDIT3_HUMAN DNA Damage Inducible Transcript 3 DNA damage-inducible transcript 3 protein GADD 153 GADD153 Growth Arrest and DNA Damage Inducible Protein 153 Growth arrest and DNA damage inducible protein GADD153 Growth arrest and DNA damage-inducible protein GADD153 MGC4154
Images
HA722854_1.jpg Fig1: Western blot analysis of DDIT3 on different lysates with Rabbit anti-DDIT3 antibody (HA722854) at 1/5,000 dilution.

Lane 1: HeLa cell lysate
Lane 2: HeLa treated with 2μg/mL tunicamycin for 8 hours cell lysate
Lane 3: C2C12 cell lysate
Lane 4: C2C12 treated with 2μg/mL thapsigargin for 8 hours cell lysate
Lane 5: C6 cell lysate
Lane 6: C6 treated with 2μg/mL tunicamycin for 8 hours cell lysate

Lysates/proteins at 20 µg/Lane.

Predicted band size: 19 kDa
Observed band size: 27 kDa

Exposure time: Lane 1-2: 3 minutes; Lane 3-6: 10 seconds; ECL: K1801;
4-20% SDS-PAGE gel.

Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA722854) at 1/5,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
HA722854_2.jpg Fig2: Immunocytochemistry analysis of HeLa cells treated with 2μg/mL tunicamycin for 8 hours labeling DDIT3 with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
HA722854_3.jpg Fig3: Immunocytochemistry analysis of C2C12 cells treated with 2μg/mL thapsigargin for 8 hours labeling DDIT3 with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
HA722854_4.jpg Fig4: Immunocytochemistry analysis of C6 cells treated with 2μg/mL tunicamycin for 8 hours labeling DDIT3 with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution.

Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-DDIT3 antibody (HA722854) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.

Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
HA722854_5.jpg Fig5: Flow cytometric analysis of C2C12 cells treated with 2μg/mL thapsigargin for 8 hours labeling DDIT3.

Cells were fixed and permeabilized. Then stained with the primary antibody (HA722854, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Note: All products are “FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE”.